Aubin, H-J

Billing, C B

Bobak, A

Britton, J R

Gong, J

Oncken, C

Reeves, K R

Williams, K E

English

PubMed

H-J Aubin

A Bobak

J R Britton

C Oncken

C B Billing

J Gong

K E Williams

K R Reeves

Crossref

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

3,5-Bicyclic Aryl Piperidines: A novel class of potent a4b2 selective neuronal nicotinic receptor partial agonists for smoking cessation.

A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin

A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch.

A randomized, placebo-controlled trial of varenicline, a selective alpha-4 beta-2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clin Ther 2007;29:1027–39. Smoking 724 Thorax 2008;63:717–724.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.

Antidepressants for smoking cessation (Review). Cochrane Database Syst Rev

Disease Control and Prevention. Cigarette smoking among adults – United States,

Disease Control and Prevention. Use of FDA-approved pharmacologic treatments for tobacco dependence – United States 1984–1998. MMWR Morb Mortal Wkly Rep

Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.

Efficacy and safety of varenicline, an alpha-4 beta-2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Electric orange book: approved drug products with therapeutic equivalence evaluations.

Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control

Individual differences in smoking reward from de-nicotinized cigarettes. Nicotine Tob Res

Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev

Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Exp Clin Psychopharmacol

Outcome criteria in smoking cessation trials: proposal for a common standard.

Pharmacological profile of the alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Prescribing information drug insert.

Product pack insert.

Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin

Shape of the relapse curve and long-term abstinence among untreated smokers.

Signs and symptoms of tobacco withdrawal.

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy.

Stopping smoking can cause constipation.

Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guidelines. Respir Care

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Varenicline versus bupropion for smoking cessation: a pooled analysis.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2569194

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

Abstract

Similar works

Full text

Available Versions

Crossref